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Abstract
Background: It is unclear whether an upper gastrointestinal bleed is an isolated gastrointestinal event or an indicator of a
deterioration in a patient’s overall health status. Therefore, we investigated the excess causes of death in individuals after a
non-variceal bleed compared with deaths in a matched sample of the general population.
Methods and Findings: Linked longitudinal data from the English Hospital Episodes Statistics (HES) data, General Practice
Research Database (GPRD), and Office of National Statistics death register were used to define a cohort of non-variceal
bleeds between 1997 and 2010. Controls were matched at the start of the study by age, sex, practice, and year. The excess
risk of each cause of death in the 5 years subsequent to a bleed was then calculated whilst adjusting for competing risks
using cumulative incidence functions. 16,355 patients with a non-variceal upper gastrointestinal bleed were matched to
81,523 controls. The total 5-year risk of death due to gastrointestinal causes (malignant or non-malignant) ranged from 3.6%
(#50 years, 95% CI 3.0%–4.3%) to 15.2% ($80 years, 14.2%–16.3%), representing an excess over controls of between 3.6%
(3.0%–4.2%) and 13.4% (12.4%–14.5%), respectively. In contrast the total 5-year risk of death due to non-gastrointestinal
causes ranged from 4.1% (#50 years, 3.4%–4.8%) to 46.6% ($80 years, 45.2%–48.1%), representing an excess over controls
of between 3.8% (3.1%–4.5%) and 19.0% (17.5%–20.6%), respectively. The main limitation of this study was potential
misclassification of the exposure and outcome; however, we sought to minimise this by using information derived across
multiple linked datasets.
Conclusions: Deaths from all causes were increased following an upper gastrointestinal bleed compared to matched
controls, and over half the excess risk of death was due to seemingly unrelated co-morbidity. A non-variceal bleed may
therefore warrant a careful assessment of co-morbid illness seemingly unrelated to the bleed.
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Introduction
The causes of excess deaths following an acute medical event
can demonstrate areas where mortality can be reduced. For
example three-quarters of deaths following a myocardial infarction
were found to be due to the cardiovascular disease itself, but after a
stroke two-fifths of deaths were found to be due to related
respiratory infections and cardiovascular disease [1,2]. In contrast
the long term outcomes of upper gastrointestinal haemorrhage are
poorly understood, despite it being the most frequent cause of
gastroenterology admission to acute medicine. Controlled studies
have been limited to two cohorts with peptic ulcer disease from the
early 1990s with fewer than 150 deaths [3,4]. These showed an
excess mortality unrelated to the bleeding event itself but the
studies disagreed on which causes of death were increased. Other
studies were uncontrolled [5,6], smaller [7], not population based
[8], or were so long ago as to be mostly irrelevant with respect to
current management of bleeding [9]. Furthermore, an increasing
proportion of non-variceal bleeds over the last two decades do not
have underlying peptic ulcers, thereby reducing the relevance of
these previous cause-of-death studies to current clinical practice
[10].
Therefore, to identify whether interventions might reduce
mortality following an upper gastrointestinal non-variceal bleed
we investigated the causes of death by age and time in the 5 y
following a non-variceal bleed, and compared them with deaths in
a matched sample of the general population.
Methods
Data
A cohort study was designed using linked longitudinal data from the
linked English Hospital Episodes Statistics (HES) data, General
Practice Research Database (GPRD), and Office of National Statistics
death register. This data linkage records all primary care events,
hospital admissions, and causes of death between 1st April 1997 to 31st
August 2010 for 3% of the English population. Because of the
comprehensive English primary care system the population registered
to the GPRD is representative of the general English population [11].
The data sources are subject to quality checks and a practice’s data is
Table 1. Numbers, deaths, and follow-up time by exposure to upper gastrointestinal bleeding within 5 y of bleeding.
Characteristics Exposed Percent Unexposed Percent
Cohort (n) 16,355 — 81,523 —
Deaths 6,424 — 11,643 —
Person-years 40,137 — 274,043 —
Gender (n=patients)
Male 8,800 53.8 43,836 53.8
Female 7,555 46.2 37,687 46.2
Age (n=patients)
,60 y 4,698 28.7 24,009 29.5
60–69 y 2,512 15.4 13,223 16.2
70–79 y 4,178 25.5 22,110 27.1
$80 y 4,967 30.4 22,181 27.2
Number of deaths
(percentage shown of all
deaths)
Neoplasms 1,948 30.3 2,615 22.5
Circulatory 1,704 26.5 4,443 38.2
Digestive 1,042 16.2 390 3.3
Respiratory 787 12.3 1,724 14.8
Genitourinary 138 2.1 265 2.3
Psychiatric 119 1.9 398 3.4
Neurological 110 1.7 321 2.8
Infections 99 1.5 122 1.0
External 88 1.4 228 2.0
Symptoms 80 1.2 346 3.0
Endocrine 77 1.2 158 1.4
Musculoskeletal 49 0.8 95 0.8
Dermatological 27 0.4 35 0.3
Haematological 26 0.4 19 0.2
Poisoning 13 0.2 9 0.1
Congenital 6 0.1 6 0.1
Unassigned code 7 0.1 7 0.1
Uncoded 104 1.6 462 4.0
doi:10.1371/journal.pmed.1001437.t001
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only used when it is of high enough quality to be used in research [12].
This is referred to as the up to research standard time period and is
defined separately for each primary care practice. Ethical approval for
this study was obtained from the Independent Scientific Advisory
Committee for Medicines and Healthcare products Regulatory
Agency (MHRA) database research.
Cohort
Population. We selected as exposed all patients with a first
non-variceal upper gastrointestinal bleed. A bleed was defined by
a specific code for an upper gastrointestinal non-variceal bleed in
either primary or secondary care who had a supporting code in
the linked dataset. We previously described and published this
methodology [13]. All patients in the study therefore had a
hospital admission at the time of their bleed, reflecting national
guidelines at the time of the study [14]. Variceal bleeds or non-
specific gastrointestinal bleed codes with either a lower gastro-
intestinal diagnosis or procedure were excluded. Further exclu-
sions were temporary patients, children under 16 y old, cases
with invalid date codes, or cases outside the up to research
standard observed time periods. The observed up to research
standard time periods began at the latest of: the start of the linked
data (1st April 1997), the date the patient registered with a
practice, or the up to research standard date of that practice. It
ended at the earliest of: the last date for the linked primary care
data (31st August 2010), the date a patient transfered out of care
of the practice, a patient’s death, or the last date of data collection
from that practice.
Table 2. Mortality rate per 100 person-years, stratified by cause of death by ICD10 headings in the 5 y post bleed.
Cause of Death
1st month
Deaths (n) Rate (95% CI)
1 mo to 1 y
Deaths (n) Rate (95% CI)
1 y to 5 y
Deaths (n) Rate (95% CI)
Neoplasmsa 521 41.3 (37.9–45.0) 920 8.4 (7.8–8.9) 507 1.8 (1.7–2.0)
Oesophagusb 85 6.7 (5.5–8.3) 151 1.4 (1.2–1.6) 53 0.2 (0.1–0.2)
Stomach 61 4.8 (3.8–6.2) 152 1.4 (1.2–1.6) 52 0.2 (0.1–0.2)
Colon 21 1.7 (1.1–2.6) 37 0.3 (0.2–0.5) 35 0.1 (0.1–0.2)
Pancreas 37 2.9 (2.1–4.1) 66 0.6 (0.5–0.8) 19 0.1 (0.0–0.1)
Digestive (other) 39 3.1 (2.3–4.2) 58 0.5 (0.4–0.7) 46 0.2 (0.1–0.2)
Respiratory 50 4.0 (3.0–5.2) 88 0.8 (0.6–1.0) 75 0.3 (0.2–0.3)
Skin or bone 12 1.0 (0.5–1.7) 18 0.2 (0.1–0.3) 9 0.0 (0.0–0.1)
Breast 28 2.2 (1.5–3.2) 27 0.2 (0.2–0.4) 21 0.1 (0.0–0.1)
Prostate 34 2.7 (1.9–3.8) 55 0.5 (0.4–0.7) 43 0.2 (0.1–0.2)
Other or benign 165 13.1 (11.2–15.3) 276 2.5 (2.2–2.8) 161 0.6 (0.5–0.7)
Circulatory 378 30.0 (27.1–33.2) 621 5.6 (5.2–6.1) 705 2.5 (2.3–2.7)
Rheumatic disease #5 — #5 — 17 0.1 (0.0–0.1)
Hypertensive disease #5 — 6 0.1 (0.0–0.1) 15 0.1 (0.0–0.1)
IHD 134 10.6 (9.0–12.6) 209 1.9 (1.7–2.2) 292 1.0 (0.9–1.2)
Pulmonary circulatory disease 20 1.6 (1.0–2.5) 12 0.1 (0.1–0.2) 16 0.1 (0.0–0.1)
Heart - other 50 4.0 (3.0–5.2) 104 0.9 (0.8–1.1) 113 0.4 (0.3–0.5)
CVA 83 6.6 (5.3–8.2) 197 1.8 (1.6–2.1) 197 0.7 (0.6–0.8)
Other circulatory 47 3.7 (2.8–5.0) 48 0.4 (0.3–0.6) 42 0.2 (0.1–0.2)
Respiratory 189 15.0 (13.0–17.3) 302 2.7 (2.5–3.1) 296 1.1 (0.9–1.2)
Respiratory infections 86 6.8 (5.5–8.4) 130 1.2 (1.0–1.4) 119 0.4 (0.4–0.5)
Chronic airway disease 48 3.8 (2.9–5.1) 71 0.6 (0.5–0.8) 108 0.4 (0.3–0.5)
ILD 16 1.3 (0.8–2.1) 23 0.2 (0.1–0.3) 22 0.1 (0.1–0.1)
Respiratory - other 39 3.1 (2.3–4.2) 78 0.7 (0.6–0.9) 47 0.2 (0.1–0.2)
Digestive 608 48.2 (44.6–52.2) 258 2.3 (2.1–2.7) 176 0.6 (0.5–0.7)
Upper GI 436 34.6 (31.5–38.0) 96 0.9 (0.7–1.1) 43 0.2 (0.1–0.2)
Lower GI 80 6.3 (5.1–7.9) 52 0.5 (0.4–0.6) 51 0.2 (0.1–0.2)
Liver or gallbladder 82 6.5 (5.2–8.1) 100 0.9 (0.7–1.1) 74 0.3 (0.2–0.3)
Pancreas 6 0.5 (0.2–1.1) 8 0.1 (0.0–0.1) 8 0.0 (0.0–0.1)
Other 171 13.6 (11.7–15.8) 329 3.0 (2.7–3.3) 339 1.2 (1.1–1.4)
Uncoded 45 3.6 (2.7–4.8) 38 0.3 (0.3–0.5) 21 0.1 (0.0–0.1)
Total 1,912 151.7 (145.1–158.7) 2,468 22.4 (21.6–23.4) 2,044 7.3 (7.0–7.7)
Due to anonymisation numbers in cells with five or fewer events are not shown.
aBold headings indicate ICD 10 chapter headings.
bNon-bold headings indicate ICD 10 subchapter headings.
CVA, cerebrovascular accident; GI, gastrointestinal; IHD, ischaemic heart disease; ILD, interstitial lung disease.
doi:10.1371/journal.pmed.1001437.t002
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Patients who had a bleed recorded prior to the observed up to
standard time period of our database, either in the hospital
admissions database or in the longitudinal primary care record,
were excluded. Bleeds prior to the observed up to research
standard time period should be captured by the longitudinal
primary care record, as historical records would be transferred
with a patient when they change their primary care provider.
Patients were required to be registered with a new primary care
Figure 1. Cumulative incidence function for each cause of death following non-variceal bleeding #50 y. Cause of death by ICD 10
chapter over 5 y follow-up following a bleed. Numbers at risk at beginning of each year of follow-up shown beneath legend. Adjusted for gender and
competing risks.
doi:10.1371/journal.pmed.1001437.g001
Figure 2. Cumulative incidence function for each cause of death following non-variceal bleeding 50–59 y. Cause of death by ICD 10
chapter over 5 y follow-up following a bleed. Numbers at risk at beginning of each year of follow-up shown beneath legend. Adjusted for gender and
competing risks.
doi:10.1371/journal.pmed.1001437.g002
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practice for at least 3 mo prior to any upper gastrointestinal
bleed event to avoid including prevalent cases that might have
been coded at the initial registration consultation. Follow-up
started on the day of the first bleed.
Comparison group. For each case five age- (65 y) and sex-
matched controls were selected who were alive at the time of the
bleed and registered to the same general practice. Controls were
required to have been registered with the primary care practice for
Figure 3. Cumulative incidence function for each cause of death following non-variceal bleeding 60–69 y. Cause of death by ICD 10
chapter over 5 y follow-up following a bleed. Numbers at risk at beginning of each year of follow-up shown beneath legend. Adjusted for gender and
competing risks.
doi:10.1371/journal.pmed.1001437.g003
Figure 4. Cumulative incidence function for each cause of death following non-variceal bleeding 70–79 y. Cause of death by ICD 10
chapter over 5 y follow-up following a bleed. Numbers at risk at beginning of each year of follow-up shown beneath legend. Adjusted for gender and
competing risks.
doi:10.1371/journal.pmed.1001437.g004
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at least 3 mo prior to the match date to be consistent with the
definition for cases.
Causes of death. Dates of death for the whole cohort were
extracted from the linked data using the Office of National
Statistics death register. All deaths in England are coded and
recorded in the Office of National Statistics Death register
from death certificates using the World Health Organization
(WHO) guidelines [15]. These define causes of death by
Figure 5. Cumulative incidence function for each cause of death following non-variceal bleeding $80 y. Cause of death by ICD 10
chapter over 5 y follow-up following a bleed. Numbers at risk at beginning of each year of follow-up shown beneath legend. Adjusted for gender and
competing risks.
doi:10.1371/journal.pmed.1001437.g005
Figure 6. Excess cumulative incidence function for each cause of death following non-variceal bleeding#50 y. Excess death by ICD 10
chapter over 5 y follow-up following a bleed compared to age, sex, year, and practice matched controls. Numbers at risk at beginning of each year of
follow-up shown beneath legend. Adjusted for gender and competing risks.
doi:10.1371/journal.pmed.1001437.g006
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International Classification of Diseases version 2010 (ICD 10)
codes with the main underlying cause established for each
death using standardised rules. For this study we analysed the
underlying cause of death by the most frequent ICD 10
chapter headings of neoplasms (ICD chapters C and D),
circulatory (ICD chapter I: including cerebrovascular and
ischaemic heart disease), respiratory (ICD chapter J), digestive
disease (ICD chapter K), and the remaining less frequent
chapter headings grouped together in an ‘‘other causes’’
category. Neoplasms were further subdivided between upper
Figure 7. Excess cumulative incidence function for each cause of death following non-variceal bleeding 50–59 y. Excess death by ICD
10 chapter over 5 y follow-up following a bleed compared to age, sex, year, and practice matched controls. Numbers at risk at beginning of each year
of follow-up shown beneath legend. Adjusted for gender and competing risks.
doi:10.1371/journal.pmed.1001437.g007
Figure 8. Excess cumulative incidence function for each cause of death following non-variceal bleeding 60–69 y. Excess death by ICD
10 chapter over 5 y follow-up following a bleed compared to age, sex, year, and practice matched controls. Numbers at risk at beginning of each year
of follow-up shown beneath legend. Adjusted for gender and competing risks.
doi:10.1371/journal.pmed.1001437.g008
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gastrointestinal malignancies and other neoplasms. Causes of
death prior to 2001 were coded using ICD 9 and were
therefore mapped onto the relevant ICD 10 chapter headings.
Follow-up. Patients were followed up from the date of
gastrointestinal bleed or matching until either death or censoring
of the patient record (defined as the end of the observed up to
research standard time period). Follow-up did not stop if a
subsequent bleed occurred but continued until death or censoring
of the patient record.
Analysis
Crude mortality rates. Crude numbers of deaths and rates
per 1,000 person-years following upper gastrointestinal bleed were
calculated overall and by the most frequent ICD 10 chapter
headings. These rates were then stratified by age group and year
post bleed. Age was grouped into ,50, 50–59, 60–69, 70–79, and
$80-y-old. The time post bleed was stratified into the first 30 d,
1 mo to 1 y, and 1 y to 5 y.
Adjusted analysis. Crude mortality rates were calculated for
those still alive and at risk at each time point. However, when
studying specific causes of death this group of survivors might not
be representative of the initial cohort, since deaths from other
causes can select out those with relevant risk factors. One method
to adjust for this bias uses cumulative incidence functions (CIFs)
that calculate the probability of overall survival from all causes,
combined with the instantaneous hazard of death for each specific
cause [16]. CIF were therefore calculated for each cause of death
using baseline survival functions and hazard ratios from Cox
proportional hazards modelling. The models were stratified by age
group, adjusted for gender, and split at 1 mo, 1 y, 3 y, and 5 y.
The excess risk was calculated as the difference between the CIF
for cases exposed to a bleed and the CIF for unexposed controls.
95% CIs were derived by bootstrapping (500 iterations).
Sensitivity analyses. We assessed whether the excess mor-
tality associated with a bleed for each cause of death was
confounded by pre-existing co-morbidity, excess alcohol, or
smoking status, and whether it varied by the site of bleed. Pre-
existing co-morbidity was measured by the Charlson index (a
weighted co-morbidity score predicting 1 y mortality [17]) using
both hospital and primary care records prior to 2 mo before the
bleeding episode. Smoking and alcohol status for each patient was
derived from the information available in the linked dataset.
Smoking status was categorised as current smoker or non-smoker.
Excess alcohol status was categorised as excess alcohol use
(including consumption over the recommended limit, alcohol
dependency codes, complications from chronic alcohol abuse, or
therapy for alcohol dependency) or no excess alcohol use. Site of
bleed was categorised as oesophageal, gastric, duodenal, or
unspecified.
Results
16,355 unique individuals who had a non-variceal upper
gastrointestinal bleed were identified in the linked primary and
secondary care dataset, with 6,242 subsequent deaths. 8 cases
(0.05%) could not be matched to controls and were therefore
excluded from the study. Baseline demographics are shown for the
bleed cases and the matched controls in Table 1 along with the
numbers of deaths for each of the ICD 10 chapter headings. For
clarity of presentation in the remainder of the results, deaths not
attributed to one of the most frequent ICD 10 chapter headings
were grouped together as ‘‘other causes.’’ More than 70% of the
ICD 10 ‘‘external’’ chapter causes of death were coded as either a
fall, strangling, or unspecified exposure. More than 95% of the
ICD 10 ‘‘symptoms’’ chapter causes were coded as senility. More
than 70% of the ICD 10 ‘‘musculoskeletal’’ chapter causes were
coded as either osteoporosis with fracture, rheumatoid arthritis,
osteomyelitis, or pyogenic arthritis. More than 70% of the ICD 10
‘‘dermatological’’ chapter causes of death were coded as ulcers or
cellulitis. The overall median follow-up time from index date was
Figure 9. Excess cumulative incidence function for each cause of death following non-variceal bleeding 70–79 y. Excess death by ICD
10 chapter over 5 y follow-up following a bleed compared to age, sex, year, and practice matched controls. Numbers at risk at beginning of each year
of follow-up shown beneath legend. Adjusted for gender and competing risks.
doi:10.1371/journal.pmed.1001437.g009
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3.2 y (interquartile range 0.4–5.2), and for those who were
censored without death was 4.8 y.
Out of a total of 1,536 deaths within 30 d of a bleed, 306 (17%) had
an underlying cause coded as an upper gastrointestinal bleed
determined by the following ICD 10 codes: gastrointestinal haemor-
rhage K922 (n=133), chronic duodenal ulcer with haemorrhage K264
(n=92), chronic gastric ulcer with haemorrhage K254 (n=44), and
chronic peptic ulcer with haemorrhage K274 (n=27). The combined
codes of chronic duodenal ulcer with haemorrhage and perforation
K266, acute duodenal ulcer with haemorrhage K260, oesophageal
haemorrhage K228, acute gastric ulcer with haemorrhage K250, and
chronic gastric ulcer with haemorrhage and perforation K256 were the
underlying cause in a further ten deaths.
Crude Mortality Rates
The crude mortality rate in the first 5 y following an upper
gastrointestinal bleed was 16.0 per 100 person-years, 95% CI 15.6–
16.4. This number declined over time from 35.7 deaths per 100
person-years (95% CI 34.7–36.8) in the first year to 7.3 deaths per 100
person-years (95% CI 7.0–7.7) over the subsequent 4 y. The rates and
risk of death were 10%–15% lower for women than men, but the
relative differences between causes of death were similar. Therefore
Table 2 shows the numbers of deaths and crude rates by ICD 10
category stratified by time post bleed. In the first month after a bleed
the mortality rate was increased for all causes of death, but the highest
mortality rate was from non-malignant digestive disease (48 deaths per
100 person-years), and this was mostly due to causes related to the
upper gastrointestinal tract (35 per 100 person-years). For the
remainder of the first year the highest mortality rates were from
neoplasms (8.4 per 100 person-years), half of which were from sites
outside the gastrointestinal tract. Circulatory and respiratory mortality
rates were also increased over the first year, but to a lesser extent than
for digestive disease and neoplasms. However, by 5 y the category with
the highest mortality rate was circulatory disease (2.5 per 100 person-
years). The mortality rates for each cause of death remained slightly
higher at 5 y following an upper gastrointestinal bleed than in the
matched controls (Table S1).
The mortality rates for each of the causes of death increased
with age except for the mortality rate from liver disease, which
decreased with age (Table S2). The mortality rates were higher for
each age group following an upper gastrointestinal bleed than for
the matched controls (Table S3). Mortality rates were high and fell
rapidly over the first year, therefore Tables S2 and S3 only show
mortality rates between 1 and 4 y following the bleed, when the
mortality rates were more stable. The highest mortality rate in the
younger age groups was from neoplasms and digestive disease,
whereas in older age groups the highest mortality rates were from
circulatory disease, comprising mainly ischaemic heart disease (3.2
Figure 10. Cumulative incidence function following non-variceal bleeding for cause of death $80 y. Excess death by ICD 10 chapter
over 5 y follow-up following a bleed compared to age, sex, year, and practice matched controls. Numbers at risk at beginning of each year of follow-
up shown beneath legend. Adjusted for gender and competing risks.
doi:10.1371/journal.pmed.1001437.g010
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per 100 person-years) and cerebrovascular disease (3.3 per 100
person-years).
Adjusted Analysis
The graphs in Figures 1–5 show the CIF adjusted for competing
risks for the most frequent causes of death by ICD 10 chapter
headings stratified by age group. By 5 y after an upper
gastrointestinal bleed the cumulative risk of death due to
malignant or non-malignant gastrointestinal causes ranged from
3.6% (#50 y, 95% CI 3.0%–4.3%) to 15.2% ($80 y, 95% CI
14.2%–16.3%). In contrast the CIF for death due to non-
gastrointestinal causes ranged from 4.1% (#50 y, 95% CI 3.4%–
4.8%) to 46.6% ($80 y, 95% CI 45.2%–48.1%) by 5 y following
an upper gastrointestinal bleed.
The graphs in Figures 6–10 show the excess CIF associated with
a bleed adjusted for competing risks. Overall there was an excess
CIF of 26% compared to matched controls and this peaked in the
70–79-y-old age group. The excess CIF for death due to malignant
or non-malignant gastrointestinal causes ranged from between
3.6% (#50 y, 95% CI 3.0%–4.2%) to 13.4% ($80 y, 95% CI
12.4%–14.5%). In contrast the excess CIF for death due to non-
gastrointestinal causes ranged from 3.8% (#50 y, 95% CI 3.1%–
4.5%) to 19.0% ($80 y, 95% CI 17.5%–20.6%). Therefore over
half the excess CIF was due to non-gastrointestinal causes of death.
Table 3 shows that the 95% CIs for the excess CIF values exclude
the null for all causes of death apart from respiratory disease
(which were not interpretable due to small numbers).
Sensitivity Analyses
Table 4 shows the excess mortality at 5 y associated with a bleed
when adjusted for prior co-morbidity, alcohol, or smoking.
Adjusting for smoking and alcohol had no effect on the excess
Table 3. Excess cumulative incidence function post bleed by time post bleed.
Cause of Death Age Range 1 mo 1 y 5 y
eCIF (95% CI) eCIF (95% CI) eCIF (95% CI)
Upper GI Neoplasms #50 y 0.11 (20.00 to 0.22) 0.43 (0.22–0.64) 0.61 (0.33–0.89)
50–59 y 1.15 (20.30 to 2.59) 3.11 (1.53–4.68) 3.62 (2.02–5.22)
60–69 y 1.76 (20.35 to 3.87) 5.58 (3.33–7.82) 6.58 (4.28–8.89)
70–79 y 1.47 (20.28 to 3.21) 4.76 (2.91–6.61) 5.65 (3.70–7.59)
$80 y 1.20 (20.12 to 2.52) 3.83 (2.35–5.31) 4.41 (2.79–6.03)
Other Neoplasms #50 y 0.51 (0.27–0.75) 1.00 (0.64–1.36) 1.29 (0.86–1.72)
(Not Upper GI) 50–59 y 1.45 (0.93–1.96) 3.45 (2.63–4.27) 4.17 (3.17–5.18)
60–69 y 2.39 (1.83–2.96) 5.65 (4.54–6.75) 6.64 (5.22–8.06)
70–79 y 1.82 (1.39–2.25) 4.68 (3.70–5.65) 5.23 (3.87–6.59)
$80 y 1.95 (1.50–2.40) 4.82 (3.52–6.11) 4.38 (2.65–6.12)
Cardiovascular #50 y 0.14 (0.02–0.26) 0.38 (0.17–0.60) 0.62 (0.32–0.92)
50–59 y 0.37 (0.11–0.64) 1.44 (0.92–1.96) 2.36 (1.53–3.19)
60–69 y 1.12 (0.74–1.49) 3.04 (2.31–3.78) 4.66 (3.52–5.80)
70–79 y 2.40 (1.89–2.91) 5.25 (4.19–6.32) 6.44 (4.76–8.12)
$80 y 3.92 (3.21–4.63) 8.66 (6.30–11.03) 7.64 (3.97–11.30)
Respiratorya #50 y 0.03 — 0.24 — 0.31 —
50–59 y 0.16 — 0.58 — 1.04 —
60–69 y 0.56 — 1.28 — 2.08 —
70–79 y 0.97 — 2.46 — 3.24 —
$80 y 2.28 — 4.95 — 4.56 —
Digestive #50 y 1.01 (0.28–1.75) 2.28 (1.43–3.14) 3.04 (2.06–4.02)
50–59 y 1.96 (0.25–3.67) 4.04 (2.23–5.84) 5.33 (3.45–7.22)
60–69 y 1.93 (0.27–3.59) 3.15 (1.47–4.83) 3.90 (2.17–5.63)
70–79 y 2.60 (0.67–4.53) 4.01 (2.05–5.98) 4.45 (2.46–6.43)
$80 y 6.43 (2.43–10.42) 8.19 (4.20–12.17) 8.56 (4.58–12.54)
Other #50 y 0.26 (0.09–0.44) 0.95 (0.61–1.29) 1.65 (1.10–2.19)
50–59 y 0.53 (0.21–0.85) 1.90 (1.26–2.53) 3.09 (2.17–4.02)
60–69 y 0.70 (0.42–0.98) 1.85 (1.31–2.38) 2.37 (1.63–3.11)
70–79 y 0.92 (0.65–1.19) 2.58 (1.99–3.17) 3.06 (2.15–3.97)
$80 y 2.29 (1.78–2.80) 4.37 (2.96–5.78) 2.54 (0.58–4.50)
95% CIs obtained by bootstrapping (500 iterations).
aCIs were too unstable to be interpretable for respiratory causes of death due to small numbers.
eCIF, excess CIF; the absolute difference in the CIF between patients with non-variceal bleeding and age, sex, year, and general practice matched controls without non-
variceal bleeding; GI, gastrointestinal.
doi:10.1371/journal.pmed.1001437.t003
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mortality, whilst adjusting for prior co-morbidity slightly reduced
the point estimates for non-gastrointestinal co-morbidity. However
the significant excess risk of death for all causes persisted, with CIs
overlapping with those from the main analysis. When we
examined in more detail the prior medical history of patients
exposed to a bleed, 54% of those who subsequently died from a
neoplasm did not have a neoplasm coded before the bleed, and
41% of those who died from a cardiovascular death did not have
cardiovascular disease coded before the bleed. Finally when
examined by bleed site the excess risks were unchanged from the
main analysis (Table S4).
Discussion
We determined the cumulative excess risk of death in the 5 y
following a non-variceal upper gastrointestinal bleed. We have done
this in a large unselected population cohort and assessed the
underlying cause whilst adjusting for competing risks. This analysis
showed that although there was an excess risk of death from
gastrointestinal causes, more than half the total excess risk of death
was from unrelated non-gastrointestinal causes. The largest absolute
increases were from neoplastic and cardiovascular disease, but half
of those who died from these two causes were not diagnosed prior to
the upper gastrointestinal bleed. This finding suggests that, in
addition to indicating upper gastrointestinal pathology, an upper
gastrointestinal bleed is either a cause of non-gastrointestinal co-
morbidity or an indicator of existing co-morbidity (whether
diagnosed or undiagnosed). Our findings contrast with those for
other acute life-limiting medical events. For example, three-quarters
of the excess death following a myocardial infarction were shown to
be due to the cardiovascular disease, and two-thirds of the excess
death following a stroke were shown to be due to related respiratory
infections, cardiovascular disease, or the cerebrovascular disease
itself [1,2].
The main strengths of this study compared to previous studies
are its larger size, follow-up, competing risk adjustment, and
general population setting. These factors allowed us to calculate
accurate, unbiased, and more detailed mortality rates for different
causes of death than has previously been done to our knowledge.
We used linked electronic primary and secondary health care
records in which the definition of bleeding was previously found
to be accurate. In HES the incidence of peptic ulcer haemor-
rhage (1992–1995) was comparable to the 1993 regional BSG
audit (32 versus 29 per 100,000 per year, respectively) [18]. More
recently similar numbers of all upper gastrointestinal bleed
hospital admissions and related procedures were recorded in
HES as were recorded in the 2007 prospective national UK audit
[19]. In the GPRD the positive predictive value of an upper
gastrointestinal bleed code was 99% using anonymised chart
Table 5. Previous literature on long term outcome following peptic ulcer cohorts with follow-up over 30 d.
First Author Operation
Year
Published
[citation]
Follow-up
(y)
Total
Deaths Cause of Death (Percent of All Deaths)
Neoplasms Cardiovasculara Respiratory Digestiveb
Any
Upper
GI Respiratory
Caygill Vagotomy 1991 [34] ? 577 32.8 2.6 12.3 — — —
McIntosh Gastric ulcer
cohort
1991 [35] 10 305 17.4 1.6 4.6 51.5 10.8 7.2
Macintyre Duodenal ulcer
operation
1994 [36] ,20 791 31.7 0.02 0.03 35.5 8.0 2.8
Lindell Unoperated
peptic ulcer
1994 [37] 12 121 26.4 5.0 — 47.1 — 9.9
Stae¨l von Holstein Partial
gastrectomy
1995 [30] ,20 399 22.3 1.8 7.5 49.9 9.5 5.3
Svanes Perforated
peptic ulcer
1999 [38] 18.8 817 10.8 1.2 3.8 13.8 4.0 8.8
Duggan Peptic ulcer
operation
1999 [39] ,20 224 10.7 — — 42.9 13.8 10.3
Smart Bleeding ulcer
cohort
1986 [9] ,8 77 16.9 1.3 1.3 24.7 5.2 6.5
Rorbaek-Madsen Bleeding ulcer
cohort
1994 [7] ,8 45 — — — — — 6.7
Kubba Bleeding ulcer
cohort
1997 [8] ,6.5 30 10.0 — — 66.7 16.7 6.7
Hudson Bleeding ulcer
cohort
1995 [3] 2.8 (mean) 142 23.9 3.5 7.0 34.5 19.7 5.6
Ruigomez Bleeding ulcer
cohort
2000 [4] 2.8 (mean) 155 12.9 — — 36.8 17.4 9.0
We searched PubMed with no restrictions for ‘‘Cause of death’’[Mesh] AND (‘‘Peptic Ulcer’’[Mesh] OR ‘‘Gastrointestinal hemorrhage’’[Mesh]) and also examined the
references of selected papers from the search results.
aCardiovascular definitions varied from ischaemic heart disease only to including cerebrovascular disease.
bDigestive disease definitions varied from peptic ulcer related to non-malignant GI disease.
GI, gastrointestinal.
doi:10.1371/journal.pmed.1001437.t005
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review [20,21]. We further strengthened the case definition for
our study by requiring evidence from both databases to be
present to define a bleed [13].
A possible weakness of our study is the potentially imperfect data
on some recognised risk factors for the excess mortality. These data
may have caused us to overestimate the excess mortality associated
with upper gastrointestinal bleeding. However, the GPRD contains
comprehensive recording of all available diagnoses and prescrip-
tions, and with the addition of information from hospital records,
any bias from underreporting of co-morbidities will have been
minimised. Underreporting might have occurred for alcohol and
smoking; however, these risk factors did not show any important
confounding of the association between upper gastrointestinal
bleeding and excess mortality at their current level of ascertainment,
so it is unlikely any increased reporting would account for the
magnitude of the association we identified.
The information on the fact and cause of death in our study is
from the Office of National Statistics death registry, which uses
standardised WHO guidelines to extract information from death
certificates. Although death certificates can sometimes be impre-
cise, they are the official legal requirement for ascertaining the
cause of death. As a consequence, death certificates are the only
standardised method to extract cause of death information across a
large population. Here, the underlying cause of death information
was used to avoid the effect of changes in coding requirements
over time [22].
Although the Charlson index was not directly developed for
routine records, longer term follow-up, or cause specific mortality,
we believe its original purpose in predicting all cause mortality
using diagnosed co-morbidity was suitably similar to our study to
be useful [17]. Furthermore the Charlson index has been validated
in many different contexts including routine primary care and
hospital admission data [23–26]. Other co-morbidity scores that
could be used, such as the Elixhauser index or a simple counts of
diagnoses, have been validated less frequently and in fewer
contexts. However, some of these other scores also include other
outcomes, such as financial cost, which are not necessarily a
measure of the predicted mortality from a disease. The Charlson
index was therefore selected as the most appropriate co-morbidity
score for our study.
Previous studies of cause of death following upper gastrointes-
tinal bleeding were identified by a PubMed search (using the
search terms ‘‘Cause of death’’[Mesh] AND (‘‘Peptic Ulcer’’
[Mesh] OR ‘‘Gastrointestinal hemorrhage’’[Mesh]) across all
years up to September 2012) and by examining the references of
selected papers from the search results. There were a number of
studies of cause of death during the first 30 d following an upper
gastrointestinal bleed [5,6,27–29]. The largest was from Hong
Kong; however, it assessed only peptic ulcer bleeds from one
hospital. Furthermore it only reported deaths from each cause
with no comparison group [6].
In contrast, there have been only a few studies examining causes
of death in the long term following a bleed. Studies in the 1980s
and 1990s followed up peptic ulcer cohorts post surgical treatment
rather than upper gastrointestinal bleeds (shown in Table 5).
These studies were susceptible to the selection bias inherent in
surgical cohorts [30], and furthermore they are now dated as the
cohorts were completed in the 1980s before ulcer treatment was
radically changed by the introduction of Helicobacter pylori
eradication [31] and proton pump inhibitors [32,33]. The studies
that did follow up upper gastrointestinal bleeding included only
patients with proven peptic ulcers who had survived the first 30 d
(Table 5). The largest study by Ruigomez et al. consisted of 978
patients with 155 deaths [4]. However, cause of death information
was not available and cause of death was imputed by the most
recently recorded co-morbidity, increasing the risk of misclassifi-
cation. An upper age limit also meant that the study’s age
distribution differed considerably from our unselected cohort, so it
was no longer representative of those currently presenting with
bleeds. The next largest and arguably better study was able to
obtain death certificate data from the national death register and
was therefore similar to our study in being able to ascertain the
causes of death in a standardised manner. However, the study was
restricted to one city and to patients over 60 y old who were
hospitalised with endoscopically proven peptic ulcers (n = 487,
deaths = 142). This methodology limits the study’s generalisability
to a contemporary population and introduces a selection bias
towards those deemed suitable for an endoscopy [3]. In both
studies mortality rates were not calculated, no adjustment for
competing risks was made, and neither study had the power to
assess causes of death by age or time post bleed. In contrast, we
have been able to calculate stratified excess risks for different
causes of death adjusted for competing risks within a large
population-based cohort.
We found a considerable excess of all causes of death in
individuals following a non-variceal upper gastrointestinal bleed,
and over half of these deaths were due to non-gastrointestinal co-
morbidity, particularly neoplastic and cardiovascular disease. This
excess in deaths was not explained by co-morbidity such as cancer
or cardiovascular disease diagnosed prior to the admission.
Therefore, an upper gastrointestinal bleed may be a marker of
disease or an indicator of a deterioration in non-gastrointestinal
co-morbidity. Consequently, this analysis suggests that for patients
who have a non-variceal upper gastrointestinal bleed, re-assess-
ment of co-morbidity should be considered in the follow-up
period.
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site of bleeding. 95% CIs obtained by bootstrapping (500
iterations).
(DOC)
Author Contributions
Conceived and designed the experiments: CJC TRC JW. Analyzed the
data: CJC. Contributed reagents/materials/analysis tools: CJC TRC JW.
Wrote the first draft of the manuscript: CJC. Contributed to the writing of
the manuscript: CJC TRC JW. ICMJE criteria for authorship read and
met: CJC TRC JW. Agree with manuscript results and conclusions: CJC
TRC JW.
Causes of Excess Death after Non-Variceal Bleeding
PLOS Medicine | www.plosmedicine.org 13 April 2013 | Volume 10 | Issue 4 | e1001437
References
1. Brønnum Hansen H, Jørgensen T, Davidsen M, Madsen M, Osler M, et al.
(2001) Survival and cause of death after myocardial infarction: the Danish
MONICA study. J Clin Epidemiol 54: 1244–50.
2. Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, et al. (2003) Cause-
specific mortality after first cerebral infarction: a population-based study. Stroke
34: 1828–32.
3. Hudson N, Faulkner G, Smith SJ, Langman MJ, Hawkey CJ, et al. (1995) Late
mortality in elderly patients surviving acute peptic ulcer bleeding. Gut 37: 177–
181.
4. Ruigomez A, Rodriguez LAG, Hasselgren G, Johansson S, Wallander MA
(2000) Overall mortality among patients surviving an episode of peptic ulcer
bleeding. J Epidemiol Community Health 54: 130–133.
5. Nahon S, Pariente A, Nalet B, Hagege H, Latrive JPP, et al. (2010) Causes of
mortality related to peptic ulcer bleeding in a prospective cohort of 965 French
patients: a plea for primary prevention. Am J Gastroenterol 105: 1902–1903.
6. Sung JJY, Tsoi KKF, Ma TKW, Yung MY, Lau JYW, et al. (2009) Causes of
mortality in patients with peptic ulcer bleeding: a prospective cohort study of
10,428 cases. Am J Gastroenterol 105: 84–89.
7. Rorbaek-Madsen M, Fischer L, Thomsen H, Wara P (1994) Late outcome of
bleeding gastric ulcer: five to eight years’ follow-up. Scand J Gastroenterol 29:
983–987.
8. Kubba AK, Choudari C, Rajgopal C, Ghosh S, Palmer KR (1997) Reduced
long-term survival following major peptic ulcer haemorrhage. Br J Surg 84: 265–
268.
9. Smart HL, Langman MJ (1986) Late outcome of bleeding gastric ulcers. Gut 27:
926–928.
10. Jairath V, Barkun AN (2012) Nonvariceal upper GI bleeding: it’s not just about
peptic ulcers. Gastrointest Endosc 75: 273–5.
11. Hollowell J (1997) The General Practice Research Database: quality of
morbidity data. Popul Trends 87: 36–40.
12. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general
practitioner based computerised data resource in the United Kingdom. BMJ
302: 766–8.
13. Crooks CJ, West J, Card TR (2012) Defining upper gastrointestinal bleeding
from linked primary and secondary care data and the effect on occurrence and
28 day mortality. BMC Health Serv Res 12:392.
14. Palmer KR (2002) Non-variceal upper gastrointestinal haemorrhage: guidelines.
Gut 51 Suppl 4: iv1–iv6.
15. World Health Organisation (2004) Rules and guidelines for mortality and
morbidity coding. Chapter 4.1 Mortal. World Health Organisation, editor.
International classification of diseases and related health problems. Tenth
revision, volume 2, 2nd edition. Geneva: WHO. pp. 31–92. Available: www.
who.int/classifications.
16. Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in
epidemiology: possibilities and pitfalls. Int J Epidemiol 41: 861–870.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of
classifying prognostic comorbidity in longitudinal studies: development and
validation. J Chronic Dis 40: 373–383.
18. Higham J, Kang JY, Majeed A (2002) Recent trends in admissions and mortality
due to peptic ulcer in England: increasing frequency of haemorrhage among
older subjects. Gut 50: 460–464.
19. Crooks CJ, West J, Hearnshaw SA, Murphy MFM, Kelvin PRP, et al. (2011)
Hospital admission database or specialist national audits for monitoring
gastrointestinal bleeding? Both are vital to monitoring our clinical practice.
Gut 60: A187.
20. de Abajo FJ, Rodrı´guez LA, Montero D (1999) Association between selective
serotonin reuptake inhibitors and upper gastrointestinal bleeding: population
based case-control study. BMJ 319: 1106–9.
21. Abajo FD (2001) Risk of upper gastrointestinal bleeding and perforation
associated with low-dose aspirin as plain and enteric-coated formulations. BMC
Clin Pharmacol doi: 10.1186/1472-6904-1-1.
22. Goldacre MJ, Duncan ME, Cook-Mozaffari P, Griffith M (2003) Trends in
mortality rates comparing underlying-cause and multiple-cause coding in an
English population 1979–1998. J Public Health Med 25: 249–53.
23. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, et al. (2005) Coding
algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative
data. Med Care 43: 1130–1139.
24. Nuttall M, Van der Meulen J, Emberton M (2006) Charlson scores based on
ICD-10 administrative data were valid in assessing comorbidity in patients
undergoing urological cancer surgery. J Clin Epidemiol 59: 265–273.
25. Khan NF, Perera R, Harper S, Rose PW (2010) Adaptation and validation of
the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 11: 1.
26. Quan H, Li B, Couris CM, Fushimi K, Graham P, et al. (2011) Updating and
validating the Charlson comorbidity index and score for risk adjustment in
hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:
676–82.
27. Sung J, Lau J, Ching J, Wu J, Lee Y, et al. (2010) Continuation of low-dose
aspirin therapy in peptic ulcer bleeding. Ann Intern Med 152: 1–9.
28. Ramsoekh D, Van Leerdam M, Rauws E, Tytgat G (2005) Outcome of peptic
ulcer bleeding, nonsteroidal anti-inflammatory drug use, and infection. Clin
Gastroenterol Hepatol 3: 859–864.
29. Katschinski BD, Logan RF, Davies J, Langman MJ (1989) Audit of mortality in
upper gastrointestinal bleeding. Postgrad Med J 65: 913–917.
30. Stael von Holstein CC, Anderson H, Eriksson SB, Huldt B (1995) Mortality after
remote surgery for benign gastroduodenal disease. Gut 37: 617–22.
31. Marshall B, Warren J, Blincow E, Phillips M, Goodwin C, et al. (1988)
Prospective double-blind trial of duodenal ulcer relapse after eradication of
Campylobacter pylori. Lancet 332: 1437–1442.
32. Archambault AP, Pare P, Bailey RJ, Navert H, Williams CN, et al. (1988)
Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer
healing and pain relief. Gastroenterology 94: 1130–4.
33. Bate CM, Wilkinson SP, Bradby GV, Bateson MC, Hislop WS, et al. (1989)
Randomised, double blind comparison of omeprazole and cimetidine in the
treatment of symptomatic gastric ulcer. Gut 30: 1323–1328.
34. Caygill CP, Knowles RL, Hall R (1991) Increased risk of cancer mortality after
vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev 1: 35–7.
35. McIntosh JH, Byth K, Piper DW (1991) Causes of death amongst a population
of gastric ulcer patients in New South Wales, Australia. Scand J Gastroenterol
26: 806–11.
36. Macintyre I, F O’Brien F (1994) Death from malignant disease after surgery for
duodenal ulcer. Gut 35: 451–454.
37. Lindell G, Celebioglu F, Stael von Holstein C, Graffner H (1994) On the natural
history of peptic ulcer. Scand J Gastroenterol 29: 979–982.
38. Svanes C, Lie Sa, Lie RT, Søreide O, Svanes K (1999) Causes of death in
patients with peptic ulcer perforation: a long-term follow-up study.
Scand J Gastroenterol 34: 18–24.
39. Duggan JM, Zinsmeister AR, Kelly KA, Melton LJM (1999) Long-term survival
among patients operated upon for peptic ulcer disease. J Gastroenterol Hepatol
14: 1074–1082.
Causes of Excess Death after Non-Variceal Bleeding
PLOS Medicine | www.plosmedicine.org 14 April 2013 | Volume 10 | Issue 4 | e1001437
Editors’ Summary
Background. Acute gastrointestinal bleeding is a poten-
tially life-threatening abdominal emergency that remains a
common cause of admission to hospital. Upper gastrointes-
tinal bleeding (bleeding derived from a source above the
ligament of Treitz, which connects the fourth portion of the
duodenum to the diaphragm) is roughly four times as
common as bleeding from the lower gastrointestinal tract
and is a major cause of morbidity and mortality. Upper
gastrointestinal bleeding is also relatively common—every
year in the United States, roughly, 100,000 people are
admitted to hospital for treatment for this acute medical
emergency—and the most common cause is peptic ulcer
disease. Inflammation and tears in the mucosa are also
common causes.
Why Was This Study Done? In some acute emergencies,
such as heart attacks (myocardial infarction), the most
common cause of death relates to the associated cardiovas-
cular disease but in other emergencies, such as stroke, death
is commonly associated with other causes, such as cardio-
vascular disease and respiratory infections. However, despite
upper gastrointestinal bleeding being the most common
gastroenterology reason for admission to acute medicine,
the long term outcomes of patients who have experienced a
non-variceal upper gastrointestinal bleed are poorly under-
stood (a variceal bleed refers to catastrophic bleeding from
dilated collateral veins of the esophagus, usually seen in
patients with cirrhosis of the liver). So in this study, in order
to identify whether interventions might reduce mortality
following a non-variceal upper gastrointestinal bleed (upper
gastrointestinal bleed), the researchers used information
from an English database to investigate the causes of death
by age and time in the 5 years following such a bleed, and
compared these results with deaths in a matched sample of
the general population.
What Did the Researchers Do and Find? The researchers
used longitudinal data from the English Hospital Episodes
Statistics and General Practice Research Database to identify
all patients who were admitted to the hospital for treatment
of their first upper gastrointestinal bleed between April 1997
and August 2010. The researchers matched each case with a
control of a similar age from the same General Practice and
recorded causes of death from the whole cohort through the
linked Office of National Statistics death register. The
researchers then used a statistical method (cumulative
incidence functions) to calculate the excess risk of death for
those experiencing an upper gastrointestinal bleed compared
to controls.
Using these methods, the researchers identified 16,355
people who had an upper gastrointestinal bleed, of whom
6,242 subsequently died, and 81,523 matched controls. The
researchers found that the crude mortality rate in the first 5
years following an upper gastrointestinal bleed was 16.0 per
100 person-years. The rates and risk of death were 10%–15%
lower for women than men. In the first month after a bleed,
the mortality rate was increased for all causes of death, but
the highest mortality rate was from non-malignant digestive
disease (48 per 100 person-years), mostly linked to causes
related to the upper gastrointestinal tract (35 per 100
person-years). For the remainder of the first year, the highest
mortality rates were from malignant tumors (8.4 per 100
person-years), half of which were from sites outside the
gastrointestinal tract. The researchers also found that
circulatory and respiratory mortality rates were also in-
creased over the first year but by 5 years, circulatory disease
accounted for the highest mortality rate (2.5 per 100 person-
years). In their analysis, the researchers calculated that the
total 5-year risk of death due to gastrointestinal causes
ranged from 3.6% in people #50 years to 15.2% in people
$80 years, representing an excess risk of death of between
3.6% and 13.4%, respectively. The total 5-year risk of death
due to non-gastrointestinal causes ranged from 4.1% in
people #50 years to 46.6% in people $80 years, represent-
ing an excess risk of death of between 3.8% and 19.0%,
respectively.
What Do These Findings Mean? These findings suggest
that following an upper gastrointestinal bleed patients
experienced excess risk of all causes of death, over half of
which was due to non-gastrointestinal causes, particularly
malignant tumors and cardiovascular disease. This excess in
deaths was not explained by other simultaneous causes (co-
morbidity) such as cancer or cardiovascular disease diag-
nosed before admission for the upper gastrointestinal bleed.
An upper gastrointestinal bleed may be a marker of disease
or an indicator of deterioration in non-gastrointestinal co-
morbidity. A reassessment of non-gastrointestinal illnesses
may be warranted in patients who have upper gastrointes-
tinal bleeding.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001437.
N Wikipedia provides information on upper gastrointestinal
bleeding (note that Wikipedia is a free online encyclopedia
that anyone can edit; available in several languages)
N MedlinePlus also provides useful information for patients
on gastrointestinal bleeding
N The UK’s NHS provides guidelines on managing acute
gastrointestinal bleeding
N The Annals of Internal Medicine has published
international consensus guidelines on managing non-
variceal bleeding
N The journal Gut has published the Asia-Pacific consensus
on managing non-variceal upper gastrointestinal bleeding
Causes of Excess Death after Non-Variceal Bleeding
PLOS Medicine | www.plosmedicine.org 15 April 2013 | Volume 10 | Issue 4 | e1001437
